EFHD1 high expression was enriched in the arrhythmogenic right ventricular cardiomyopathy pathway, while low expression was enriched in the allograft rejection pathway (Fig. 3C). The gene discussed is EFHD1; the disease is Right ventricular cardiomyopathy.